{"doi":"10.5505/aot.2020.99815","title":"12-Cycle of Temozolomide Treatment is not Superior To 6-Cycle of Treatment in Glioblastoma Multiforme","abstract":null,"journal":"Acta Oncologica Turcica","year":2020,"id":597315,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1530265,"name":"serdar karakaya","orcid":null,"position":1,"is_corresponding":false},{"id":1530266,"name":"öztürk ateş","orcid":null,"position":2,"is_corresponding":false},{"id":1530267,"name":"berna oksuzoglu","orcid":null,"position":3,"is_corresponding":false},{"id":1530264,"name":"Ibrahim Karadag","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"12-Cycle of Temozolomide Treatment is not Superior To 6-Cycle of Treatment in Glioblastoma Multiforme","abstract":"GR ve AMA: Grade IV gliom olan glioblastoma multiforme (GBM), yetikinlerde en sk grlen primer beyin tmrdr. Biyopsi veya rezeksiyonu takiben, radyoterapi (RT) e zamanl ve adjuvan temozolomid (TMZ) kullanm (6 kr), yeni tehis edilmi GBM vakalar iin standart tedavi haline gelmitir. Orijinal tedavi rejimi 6 kr TEMODAL kullanmn iermesine ramen, baz merkezler daha iyi sonu elde etme umuduyla progrese olmayan hastalarda 12 veya daha fazla kr tedavi uygulamaktadr. Butedavi yaklam tartmaldr. almamzn temel amac, hastalksz sakalm (DFS) ve genel sa kalm (OS) asndan standart kombine tedavi yaklam ile tedavi edilen hastalarda TEMODAL tedavisinin uzatlmasnn (6 aydan 12 aya kadar","is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":"https://openalex.org/W3139389455","authors":[],"funders":[],"total_grants":0,"fwci":0.1125,"citation_percentile":0.48593265,"influential_citations":0,"citation_trend":[{"year":2023,"count":1}],"oa_status":"gold","license":null,"oa_locations":[{"url":"https://doi.org/10.5505/aot.2020.99815","host_type":"journal"},{"url":"https://doi.org/10.5505/aot.2020.99815","host_type":"publisher"},{"url":"http://doi.org/10.5505/aot.2020.99815","host_type":"journal"}],"fields_of_study":["Glioma Diagnosis and Treatment","Cancer Treatment and Pharmacology","Brain Metastases and Treatment"],"mesh_terms":[],"keywords":["Temozolomide","Glioblastoma","Oncology","Medicine","Internal medicine","Cancer research"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T12:56:01.026430Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}